Doç. Dr. Hande Erman

• Diabète sucré 2 publications
  Source : OpenAlex / PubMed MeSHVoir les publications

Domaines d’intérêt médical indiqués par le médecin lui-même sur sa page du site de l’établissement. Source : medipol.com.tr.

Expérience

• 2023 - 2026• Sağlık Bilimleri Üniversitesi, İstanbul Kartal Dr Lütfi Kırdar Şehir Hastanesimedipol.com.tr
• 2021 - 2023İstanbul Kartal Dr Lütfi Kırdar Şehir Hastanesimedipol.com.tr
• 2017 - 2021İstanbul Fatih Sultan Mehmet Eğitim ve Araştırma Hastanesi, İstanbulmedipol.com.tr
• 2016 - 2017İstanbul Sancaktepe Şehit İlhan Varank Eğitim ve Araştırma Hastanesimedipol.com.tr
• 2014 - 2016Kocaeli Gebze Fatih Devlet Hastanesimedipol.com.tr

Formation

• 2014Gaziosmanpaşa Taksim İlkyardım Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniğimedipol.com.tr
• 2008İstanbul Üniversitesi, Cerrrahpaşa Tıp Fakültesi, Uğur Derman İngilizce Tıp Programımedipol.com.tr

• SpécialitéMédecine internemedipol.com.trD’après la source
• ÉtablissementMEDİPOL Acıbadem Bölge Hastanesimedipol.com.trD’après la source
• Sujet de travailDiabète sucréDéduit de 2 publications · Version du modèle —D’après la source
• Publications34 publicationsOpenAlexD’après la source
• Dernière synchronisation4 novembre 2026 20:17https://medipol.com.tr/doktorlarimiz/docdr-hande-ermanmedipol.com.tr

1. Clinical presentation, anti-tTG IgA levels, and histological severity in adult celiac disease

   European Journal of Gastroenterology & Hepatology, 2026

   DOI 10.1097/meg.0000000000003178 PMID 41870907 Source : OpenAlex

2. P314 - ECE_2051 - Crooke's cell corticotroph adenoma or metastatic carcinoma? A different perspective of pitNETs: a case report

   European Journal of Endocrinology, 2026

   DOI 10.1093/ejendo/lvag096.464 Texte intégral en libre accèsSource : OpenAlex

3. Noninvasive Liver Fibrosis Indices as Indicators of Microvascular and Macrovascular Complications in Type 2 Diabetes

   Metabolic Syndrome and Related Disorders, 2024

   DOI 10.1089/met.2024.0022 PMID 38836748 4 citations (Europe PMC) Source : OpenAlex

4. Factors related to the presence of nonalcoholic fatty liver disease in patients with type 2 diabetes: a single center study

   Clinical and Experimental Hepatology, 2023

   DOI 10.5114/ceh.2023.130665 PMID 37790683 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

5. The role of ultrasound in determining the presence and severity of carpal tunnel syndrome in diabetic patients

   Journal of Investigative Medicine, 2023

   DOI 10.1177/10815589231167360 PMID 37148181 2 citations (Europe PMC) Source : OpenAlex

6. Relationship between Metabolic Syndrome Components and COVID-19 Disease Severity in Hospitalized Patients: A Pilot Study

   Canadian Journal of Infectious Diseases and Medical Microbiology, 2022

   DOI 10.1155/2022/9682032 PMID 36061633 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

7. COVID-19 Pneumonia in Patients with Impaired Fasting Glucose, Newly Diagnosed Diabetes and Pre-Existing Diabetes: A Tertiary Center Experience

   Journal of Investigative Medicine, 2022

   DOI 10.1136/jim-2022-002363 PMID 35654475 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

8. Success rate in achieving guideline targets for lipid parameters for atherosclerotic cardiovascular risk prevention in patients with type 2 diabetes mellitus: A retrospective analysis

   Southern Clinics of Istanbul Eurasia, 2022

   DOI 10.14744/scie.2022.46034 Source : OpenAlex

9. The role of Helicobacter infection on atherosclerosis in diabetic patients

   International Journal of Diabetes in Developing Countries, 2022

   DOI 10.1007/s13410-022-01145-5 Texte intégral en libre accèsSource : OpenAlex

10. Role of serum adropin measurement in the assessment of insulin resistance in obesity

    Journal of Investigative Medicine, 2021

    DOI 10.1136/jim-2021-001796 PMID 34016737 11 citations (Europe PMC) Source : OpenAlex